| ES2091816T3 (en) | 1989-02-10 | 1996-11-16 | Cetus Oncology Corp | MONOCLONAL ANTIBODIES OF THE MACROPHAGUS COLONY STIMULATING FACTOR (M-CSF) RECOGNIZING A NEUTRALIZING CONFORMATIONAL EPITOPE. |
| CH686365A5 (en) | 1992-10-06 | 1996-03-15 | Werner Hofliger | Mobile crane. |
| JP4891477B2 (en) | 1997-10-02 | 2012-03-07 | マックス−プランク−ゲゼルシャフト ツール フォーデルング デル ヴィッセンシャフテン エー．ヴェー． | Methods for the regulation of angiogenesis and / or development of side arteries and / or other arteries from existing arteriole networks |
| US6737056B1 (en)* | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| IL142025A0 (en) | 1999-07-20 | 2002-03-10 | Morphosys Ag | Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds |
| EP1223980B1 (en) | 1999-10-28 | 2003-05-21 | Hofbauer, Reinhold | Use of csf-1 inhibitors |
| US7108852B2 (en) | 2000-03-20 | 2006-09-19 | Warner-Lambert Company Llc | Methods of treating inflammation using antibodies to M-CSF |
| US7455836B2 (en) | 2000-05-08 | 2008-11-25 | The University Of Melbourne | Method of treatment and agents useful for same |
| EP1446138A4 (en) | 2001-10-15 | 2007-03-14 | Novartis Vaccines & Diagnostic | TREATMENT OF AN INFECTIOUS DISEASE BY THE ADMINISTRATION OF A LOW DOSE OF A TISSUE THROMBOPLASTINE ACCESS PATHWAY INHIBITOR (TFPI) |
| EP1461423B1 (en) | 2001-12-03 | 2008-05-14 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
| SE0200667D0 (en) | 2002-03-05 | 2002-03-05 | A & Science Invest Ab | Novel use of cytokine inhibitors |
| US20110091451A1 (en) | 2002-11-15 | 2011-04-21 | Kavanaugh William M | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| CN1787837A (en) | 2002-11-15 | 2006-06-14 | 希龙公司 | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| AR045563A1 (en)* | 2003-09-10 | 2005-11-02 | Warner Lambert Co | ANTIBODIES DIRECTED TO M-CSF |
| GB0325836D0 (en) | 2003-11-05 | 2003-12-10 | Celltech R&D Ltd | Biological products |
| NZ548785A (en)* | 2004-01-07 | 2011-08-26 | Novartis Vaccines & Diagnostic | M-CSF-Specific monoclonal antibody and uses thereof |
| EP1871806A2 (en) | 2005-03-08 | 2008-01-02 | Pharmacia & Upjohn Company LLC | ANTI-MAdCAM ANTIBODY COMPOSITIONS |
| US20100130904A1 (en) | 2005-07-18 | 2010-05-27 | Trustees Of Boston University | Method to inhibit proliferation and growth of metastases |
| US20080233118A1 (en)* | 2005-07-28 | 2008-09-25 | Novartis Ag | Uses Of Antibody To M-Csf |
| WO2007016285A2 (en)* | 2005-07-28 | 2007-02-08 | Novartis Ag | M-csf specific monoclonal antibody and uses thereof |
| CN101534858A (en) | 2006-01-05 | 2009-09-16 | 诺华有限公司 | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| US20090010941A1 (en) | 2007-04-09 | 2009-01-08 | University Of Massachusetts | Methods for treating HIV |
| NZ583282A (en) | 2007-08-21 | 2012-09-28 | Amgen Inc | Human c-fms antigen binding proteins |
| US20110262425A1 (en) | 2007-12-12 | 2011-10-27 | National Cancer Center | Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof |
| GB0725217D0 (en) | 2007-12-24 | 2008-02-06 | Reckitt Benckiser Uk Ltd | Cleaning device |
| US8470977B2 (en) | 2008-03-14 | 2013-06-25 | Transgene S.A. | Antibody against the CSF-1R |
| US20110142795A1 (en) | 2008-08-05 | 2011-06-16 | University Of South Florida | Methods of treating cognitive impairment |
| RU2565541C2 (en) | 2009-12-10 | 2015-10-20 | Ф.Хоффманн-Ля Рош Аг | Antibodies primarily binding to extracellular domain 4 of human csf-1r, and using them |
| BR112012020372A8 (en) | 2010-03-05 | 2018-01-02 | Hoffmann La Roche | human csf-1r binding antibody, pharmaceutical composition, nucleic acid, expression vectors, host cell and method for producing a recombinant antibody |
| KR101647871B1 (en) | 2010-03-05 | 2016-08-11 | 에프. 호프만-라 로슈 아게 | Antibodies against human csf-1r and uses thereof |
| SG10201911345WA (en) | 2010-05-04 | 2020-01-30 | Five Prime Therapeutics Inc | Antibodies that bind csf1r |
| CN104271599A (en)* | 2011-11-08 | 2015-01-07 | 辉瑞公司 | Methods of treating inflammatory diseases using anti-M-CSF antibodies |